Bilateral lung lesion caused by benign metastasizing uterine myoma
- Autores: Kotiv K.B.1,2, Khmelevskaia E.M.2, Nyuganen A.O.1, Okonechnikova D.V.1, Berlev I.V.1,2
-
Afiliações:
- N.N. Petrov National Medical Research Center for Oncology, Ministry of Health of Russia
- I.I. Mechnikov North-Western State Medical University, Ministry of Health of Russia
- Edição: Nº 11 (2025)
- Páginas: 195-200
- Seção: Clinical Notes
- URL: https://journal-vniispk.ru/0300-9092/article/view/363695
- DOI: https://doi.org/10.18565/aig.2025.53
- ID: 363695
Citar
Resumo
Background: Benign metastasizing leiomyoma is a rare condition characterized by the development of multiple slow-growing tumors composed of smooth muscle cells that form in atypical locations, primarily in lung tissue. These tumors are usually discovered after a considerable period of time following a myomectomy. This pathology is characterized by a mostly asymptomatic course, which makes it difficult to detect and often leads to accidental detection during examinations for other reasons. Despite the benign histological picture, the tumor can have a clinically aggressive course and can result in serious complications as well as increase in mortality.
Case report: The article presents a clinical case of bilateral lung lesion caused by benign metastasizing leiomyoma in a 50-year-old woman after myomectomy performed 11 years before. The disease was characterized by the latent course; the pulmonary metastases were accidentally detected during a routine examination. The therapeutic strategy included consistent surgical resections of the lesions in combination with surgical hormonal deprivation.
Conclusion: Due to the lack of approved clinical protocols for managing patients with benign metastasizing leiomyoma, it is very important to have a systematic description of such cases, since it may give an insight into the pathophysiological mechanisms and characteristics of this disease. Each clinical observation has a significant scientific value and makes it possible to obtain the information for developing the optimal treatment approaches and evaluating prognostic criteria.
Palavras-chave
Sobre autores
Khristina Kotiv
N.N. Petrov National Medical Research Center for Oncology, Ministry of Health of Russia; I.I. Mechnikov North-Western State Medical University, Ministry of Health of Russia
Autor responsável pela correspondência
Email: kotiv.onc@gmail.com
ORCID ID: 0000-0002-0486-2404
Código SPIN: 3049-8250
Scopus Author ID: 57193895371
PhD, Researcher at the Department of Oncogynecology, Teaching Assistant at the Department of Obstetrics and Gynecology
Rússia, St. Petersburg; St. PetersburgEkaterina Khmelevskaia
I.I. Mechnikov North-Western State Medical University, Ministry of Health of Russia
Email: khmelkate12@gmail.com
ORCID ID: 0009-0003-6928-3977
student at the Faculty of General Medicine
Rússia, St. PetersburgAnna Nyuganen
N.N. Petrov National Medical Research Center for Oncology, Ministry of Health of Russia
Email: annanyuganen@gmail.com
ORCID ID: 0000-0003-2685-5093
Código SPIN: 2357-6059
MD, Researcher at the Department of Pathomorphology
Rússia, St. PetersburgDaria Okonechnikova
N.N. Petrov National Medical Research Center for Oncology, Ministry of Health of Russia
Email: okonechnikovad@gmail.com
ORCID ID: 0000-0001-9364-9332
Código SPIN: 2804-7854
MD, doctor at the Radiology Department
Rússia, St. PetersburgIgor Berlev
N.N. Petrov National Medical Research Center for Oncology, Ministry of Health of Russia; I.I. Mechnikov North-Western State Medical University, Ministry of Health of Russia
Email: i.berliv@gmail.com
ORCID ID: 0000-0001-6937-2740
Scopus Author ID: 6603322008
Dr. Med. Sci., Head of the Department of Oncogynecology, Head of the Department of Obstetrics and Gynecology
Rússia, St. Petersburg; St. PetersburgBibliografia
- Хашукоева А.З., Хлынова С.А., Маркова Э.А., Каранашева А.Х. Миома матки: алгоритм ведения и лечения. Акушерство и гинекология. 2021; 3 (Приложение): 24-7. [Khashukoeva A.Z., Khlynova S.A., Markova E.A., Karanasheva A.Kh. Uterine fibroids: an algorithm for management and treatment. Obstetrics and Gynecology. 2021; 3(Suppl.): 24-7 (in Russian)].
- Малышкина А.И., Воскресенская Д.Л., Воронин Д.Н., Анциферова Ю.С., Сотникова Н.Ю., Малышкина Д.А. Иммунные механизмы регуляции роста миомы матки. Акушерство и гинекология. 2020; 2: 111-5. [Malyshkina A.I., Voskresenskaya D.L., Voronin D.N., Antsiferova Yu.S., Sotnikova N.Yu., Malyshkina D.A. Immune mechanisms of regulating the growth of uterine leiomyoma. Obstetrics and Gynecology. 2020; (2): 111-5 (in Russian)]. https://dx.doi.org/10.18565/aig.2020.2.111-115
- Al-Talib A., Tulandi T. Pathophysiology and possible iatrogenic cause of leiomyomatosis peritonealis disseminata. Gynecol. Obstet. Invest. 2010; 69(4): 239-44. https://dx.doi.org/10.1159/000274487
- Печетов А.А., Леднев А.Н., Ратникова Н.К., Волчанский Д.А. Доброкачественная метастазирующая лейомиома матки с поражением легких: проблемы диагностики и лечения. Хирургия. Журнал им. Н.И. Пирогова. 2020; 9: 85-8. [Pechetov A.A., Lednev A.N., Ratnikova N.K., Volchansky D.A. Benign metastasizing uterine leiomyoma with lung metastasis: problems of diagnosis and treatment. Pirogov Russian Journal of Surgery. 2020; (9): 85-8 (in Russian)]. https://dx.doi.org/10.17116/hirurgia202009185
- Awonuga A.O., Rotas M., Imudia A.N., Choi C., Khulpateea N. Recurrent benign metastasizing leiomyoma after hysterectomy and bilateral salpingo-oophorectomy. Arch. Gynecol. Obstet. 2008; 278(4): 373-6. https://dx.doi.org/10.1007/s00404-008-0581-z
- Awonuga A.O., Shavell V.I., Imudia A.N., Rotas M., Diamond M.P., Puscheck E.E. Pathogenesis of benign metastasizing leiomyoma: a review. Obstet. Gynecol. Surv. 2010; 65(3): 189-95. https://dx.doi.org/10.1097/OGX.0b013e3181d60f93
- Bekkers R.L., Willemsen W.N., Schijf C.P., Massuger L.F., Bulten J., Merkus J.M. Leiomyomatosis peritonealis disseminata: does malignant transformation occur? A literature review. Gynecol. Oncol. 1999; 75(1): 158-63. https://dx.doi.org/10.1006/gyno.1999.5490
- Danikas D., Goudas V.T., Rao C.V., Brief D.K. Luteinizing hormone receptor expression in leiomyomatosis peritonealis disseminate. Obstet. Gynecol. 2000; 95 (6 Pt 2): 1009-11. https://dx.doi.org/10.1016/s0029-7844(99)00587-6
Arquivos suplementares
